Month: February 2021

Achieves a record of over $11.5 million new orders since January 1st, 2021OMNIQ to provide IoT solutions for Covid 19 accelerated need to maximize efficiency, automation and touchless Supply Chain activitiesContract includes Technical Support Services and device management softwareSALT LAKE CITY, Feb. 04, 2021 (GLOBE NEWSWIRE) — OMNIQ Corp (OTCQB: OMQS) (“OMNIQ” or “the Company”), a provider of Supply Chain and Artificial Intelligence (AI)-based solutions, announced today that it has received an approximately $6.1 million purchase agreement from one of the largest food distributors in the U.S. and North America, with over $10 billion in annual revenue. The agreement calls for the supply of mobile computerized IoT equipment for thousands of trucks that deliver product in the US and Canada and is designed to collect, identify, track...

LUXEMBOURG, Feb. 04, 2021 (GLOBE NEWSWIRE) — Altisource Portfolio Solutions S.A. (NASDAQ: ASPS), an integrated service provider and marketplace for the real estate and mortgage industries, just released its annual “The State of the Originations Industry” report for 2021. The report gives an in-depth look into elements shaping the mortgage industry by highlighting the results and analysis of a survey of over 200 professionals in the U.S. origination business.The purpose of the report is to help lenders optimize their operational and marketing strategies by giving them a look at elements shaping the industry today and how other originators are planning to increase growth and efficiency this year. As expected, some responses given by mortgage origination professionals were influenced by the pandemic. Others focused on topics that affect...

Company announces second Florida acquisition this yearBRENTWOOD, Tenn, Feb. 04, 2021 (GLOBE NEWSWIRE) — IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announces its continued market expansion in Florida with the asset purchase of Willmitch Chiropractic in Tampa. The all-cash transaction is scheduled to close on Monday, February 8.Under the terms of the asset purchase agreement, the acquisition price of Willmitch Chiropractic represents a maximum 1.45 times trailing twelve months cash-flow of its existing patient base, depending on a seller earn-out provision. Additionally, Willmitch Chiropractic’s founder, Martin Willmitch, will remain with the Company...

VANCOUVER, British Columbia, Feb. 04, 2021 (GLOBE NEWSWIRE) — Ceylon Graphite Corp. (“Ceylon Graphite” or the “Company”) (TSX-V: CYL) (OTC: CYLYF) (FSE: CCY) is pleased to announce that it has designed and launched an expanded drill program at one of its properties in Sri Lanka, with drilling commencing on its H1 site.  H1 is one of 121 grids held by Ceylon Graphite’s subsidiary Sarcon Development (Pvt) Ltd under EL 222. The initial phase of the drill program will include 6 new 220 to 250 meters bore holes and has been designed to develop the parameters of the H1 mine. The Company has also retained the Geological Survey and Mines Bureau Technical Services drilling team to provide an additional drill rig and operators to complement its own drill rig and drilling team. Drilling at the H1 grid commenced in 2019, four bore holes were...

Chicago, IL, Feb. 04, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Drug Free Solution, Inc. dba Get Your Feelz On (OTC: DSOL): The Board of Directors announced today that Genie O’Malley, Founder/CEO, has stepped up to the position of Chairwoman of the Board of Directors, and Jessica Bass, business management finance alum University of Illinois, has officially accepted the position of CEO at Drug Free Solution, Inc. effective immediately.As Chairwoman, over the next twelve weeks Ms. O’Malley will, alongside of key advisory board members, focus on filling valuable board positions to assist in implementing the growth and roll-out plans of its newly elected CEO Jessica Bass and Board of Directors. Honorary Chairwoman Genie O’Malley states, “Drug Free Solution Inc. is at a turning point of a long and exhausting road of implementing...

TEL AVIV, Israel, Feb. 04, 2021 (GLOBE NEWSWIRE) — InspireMD, Inc. (“InspireMD”) (NYSE:NSPR), a medical device company focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East and Asia, today announced the pricing of an upsized underwritten public offering of securities for gross proceeds of $18 million (or $20.7 million if the underwriters exercise their option to purchase additional securities) prior to deducting underwriting discounts and estimated offering expenses payable by InspireMD.The offering is comprised of 29,032,258 Units, priced at a public offering price of $0.62 per Unit, with each Unit consisting of one share of Common Stock and one Series G Warrant to purchase one-half...

FORT LEE, NJ, Feb. 04, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Clikia Corp. (OTC:CLKA) (“Clikia” or the “Company”), an emerging leader in the global custom luxury goods marketplace, is excited to announce that it has taken a significant non-controlling investment stake in leading lab-grown diamond producer, Impossible Diamond, Inc, d/b/a Aether Diamonds (“Aether”).Through its unique IP-protected production process, Aether is the first and only diamond producer in the world to make beautiful gemstone-quality precious diamonds entirely from damaging excess CO2 in the Earth’s atmosphere. Management also believes Aether is an advantageous vehicle for investment exposure because it is an early-stage venture, allowing the Company to secure a material stake for $150K as part of a $1.5 million round.Aether has already amassed...

3 out of 4 intubated patients were discharged after treatment2 out of 4 patients were extubated within 24 hours of dosingLEXINGTON, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) — Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced positive preliminary results from its Phase 1 trial of iNKT cell therapy in patients with moderate to severe symptoms of COVID-19 through its subsidiary, AgenTus Therapeutics.AgenTus is actively accruing and treating patients with severe symptoms of COVID-19 with its proprietary allogeneic iNKT cell therapy, with dose escalation underway. Preliminary data show that of the 4 patients dosed to date, 3 patients (75%) were extubated and released...

IntentKey Revenue Grew Year-Over-Year 34% for the Fourth Quarter and 22% for the Full YearManagement to host financial results conference call on Thursday, February 11that 4:30 p.m. ETLITTLE ROCK, Ark., Feb. 04, 2021 (GLOBE NEWSWIRE) — Inuvo, Inc. (NYSE American: INUV), a leading provider of marketing technology, today announced preliminary unaudited revenue for the fourth quarter and full year 2020.Preliminary Financial Highlights:Revenue totaled $44.6 million for the full year 2020Revenue totaled $12.9 million for the fourth quarter 2020, an increase of 40% sequentiallyIntentKey revenue totaled $10.4 million for the full year 2020, an increase of 22% year-over-yearIntentKey revenue totaled $3.6 million in the fourth quarter of 2020, an increase of 34% year-over-yearValidClick revenue totaled $9.3 million for the fourth quarter...

SACRAMENTO, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) — Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer of specialty alcohols and essential ingredients, announced its Illinois Corn Processing (ICP) facility is now 2017 EXCiPACT Good Manufacturing Practices (GMP) certified.“A key component of our growth strategy is broadening our access to additional ethyl alcohol markets,” said Mike Kandris, CEO. “In conjunction with our recently announced ISO 9001 and ICH Q7 certifications, our EXCiPACT certification accomplishes that goal. EXCiPACT is an independent, globally recognized certification standard for the use of excipients in the pharmaceutical industry. Excipients are the inactive components of a drug or medication, such as solvents, carriers or tinctures. We attained these quality certifications with the assistance of our...